Gilead Sciences

Director, Global Integrated Insights – HIV

Foster City, California, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Biotechnology, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in a relevant scientific discipline, such as Epidemiology, Biostatistics, Public Health, or a related field, and have a minimum of 8 years of experience in market research, forecasting, or analytical roles within the pharmaceutical or biotechnology industry. Strong analytical skills, including proficiency in statistical modeling and data analysis techniques, are essential, along with experience in HIV therapeutics and global market dynamics.

Responsibilities

The Director, Global Integrated Insights HIV will be responsible for forecasting market trends and opportunities for HIV products, analyzing secondary data sources to generate insights, designing and managing quantitative market research projects, developing long-term strategic forecasts, and collaborating with internal and external stakeholders to inform commercial strategy and pipeline planning. They will also scope and manage the execution of these research projects, and contribute to the overall understanding of the HIV treatment landscape across key global markets.

Skills

Statistical Modeling

Data Analysis

Market Research

Forecasting

Epidemiology

Biostatistics

Public Health

HIV Therapeutics

Global Market Dynamics

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free